Is topical alprostadil an usable and reliable alternative to intracavernous injection for penile dynamic duplex ultrasonography?. (11th November 2019)

• Record Type: Journal Article
• Authors: Arcaniolo, Davide; Bellastella, Giuseppe; Manfredi, Celeste; Terribile, Marco; Giordano, Dario Ranieri; Quattrone, Carmelo; La Rocca, Roberto; De Sio, Marco; Verze, Paolo; Mirone, Vincenzo
• Is Part Of: Andrologia. Volume 52:Number 2(2020)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2019-11-11
• Subjects: erectile dysfunction -- intracavernosal injection -- penile dynamic duplex ultrasonography -- topical alprostadil; Andrology -- Periodicals; Infertility, Male -- Periodicals; 616.69
• DOI: 10.1111/and.13480
• Languages: English
• ISSNs: 0303-4569

Abstract

Abstract: No study has yet been done to evaluate topical alprostadil as a less invasive alternative vasoactive agent for Penile Dynamic Duplex Ultrasonography (PDDU) in the diagnosis of erectile dysfunction. The main aim of our study was to evaluate the usability and reliability of topical alprostadil for PDDU compared with standard intracavernous injection. A further objective was to determine the patients' preference between these two different approaches. During session A, patients received injection while during session B, they received topical alprostadil. Each patient underwent both sessions, 1 week apart from the other. A total of 80 patients were enrolled. After 20 min from drug administration, no significant difference was found between the two procedures in terms of peak systolic velocity and end‐diastolic velocity, while Erection Hardness Score was significantly higher with injection. Patients reported less pain/discomfort during the procedure in case of topical alprostadil use and an overall preference towards this examination modality. Topical alprostadil could represent a usable and reliable alternative to intracavernous injection for PDDU, with less discomfort and greater preference by patients.